GRANISETRON HYDROCHLORIDE INJECTION DIN 02322765
Status: Marketed
Holder: OMEGA LABORATORIES LIMITED
Molecule: GRANISETRON (GRANISETRON HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A04AA02 GRANISETRON |
| Original market date | 14-May-2009 |
| Current status date | 14-May-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — licence 100277, not currently licensed, last inspection rating C (2025-05-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GRANISETRON (GRANISETRON HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02308894 | APO-GRANISETRON | APOTEX INC | Tablet | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Marketed |
| 02384108 | GRANISETRON HYDROCHLORIDE INJECTION | STRIDES PHARMA CANADA INC | Solution | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Approved |
| 02558408 | GRANISETRON HYDROCHLORIDE INJECTION USP | HIKMA CANADA LIMITED | Solution | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Approved |
| 02452359 | NAT-GRANISETRON | NATCO PHARMA (CANADA) INC | Tablet | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Marketed |
| 02304708 | GRANISETRON HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Liquid | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02385414 | GRANISETRON HYDROCHLORIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02472686 | JAMP GRANISETRON | JAMP PHARMA CORPORATION | Tablet | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Dormant |
| 02088371 | KYTRIL 1MG/1ML | HOFFMANN-LA ROCHE LIMITED | Liquid | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02185881 | KYTRIL TABLETS 1MG | HOFFMANN-LA ROCHE LIMITED | Tablet | GRANISETRON (GRANISETRON HYDROCHLORIDE) 1 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10053 | 2009-02-24 | Abbreviated New Drug Submission (ANDS) |